Skip to main content

Table 1 Characteristics of patients with CF, IPF and controls

From: Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis

 

Controls

CF

IPF

Sex (M/F, n)

2/6, 8

2/3, 5

6/1, 7

Agea (years)

63 (33-76)

30 (23-38)

64 (57-70)

Current smokers (y/n)

0

0

0

Ex-smokers (y/n)

0

0

3/4

Inhaled GCS (y/n)

0

5/0

0/7

Oral GCS (y/n)

0

3/2

0/7

B2 agonist (y/n)

0

5/0

0/7

Lung function

   

   FEV1 % of predicteda

110 (82-141)

31 (22-45)

82 (66-93)

   FEV1/(F)VCa

86 (66-121)

50 (33-84)

90 (82-99)

   VC % of predicteda

104 (82-126)

54 (46-70)

66 (42-75)

   TLC % of predicteda

ND

104 (79-129)

68 (51-90)

   RV % of predicteda

ND

215 (113-318)

61 (51-101)

   % TLCO SB

ND

60 (50-71)

74 (51-110)

  1. a Data are given as mean (range). M = male, F = female, GCS = glucocorticosteroid, FEV1 = forced expiratory volume in 1 second, VC = vital capacity. TLC = total lung capacity. RV = residual volume. TLCO = diffusing capacity for carbon monoxide, ND = not determined.